Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial
Titel:
Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial
Auteur:
Ständer, Sonja Kwatra, Shawn G. Silverberg, Jonathan I. Simpson, Eric L. Thyssen, Jacob P. Yosipovitch, Gil Zhang, Fan Cameron, Michael C. Cella, Ricardo Rojo Valdez, Hernan DiBonaventura, Marco Feeney, Claire